HJB-647

N/A

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameHJB-647
Drug Alias NameHJB647HJB-647
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart Failure, Systolic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsHeart Failure, Systolic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A